TAVR replaces the damaged aortic valve without the need for open-heart surgery. In this procedure, doctors insert a thin, ...
Bihar Health Minister Mangal Pandey said on Monday that a total of 2,665 children from economically weaker families have so far undergone successful surgery and treatment under the Chief Minister Bal ...
Today, Unrivaled presented by Samsung Galaxy announced a dynamic, comprehensive partnership with Mount Sinai Medical Center ...
Camzyos, which works by blocking the actin-myosin interactions responsible for HCM and, in effect, relaxing the heart, bears ...
$11 million in proceeds expected to be received during 2026, with remainder of expected proceeds to be received in future revenue earnouts Vivasure Medical Limited (“Vivasure”) has been a strategic ...
It involves less pain, less bleeding, and there’s lower risk of infection,” said cardiothoracic surgeon Dr. Sanjay Tripathi.
“We had another quarter of strong testing services volume growth and record revenue across all segments of our business,” said John W. Hanna, President and CEO. “Our solutions selling strategy is ...
“Patients with pulmonary edema generally describe breathlessness. Sometimes they feel like they are suffocating or breathing ...
AtriCure, Inc. , a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial ...
Everyday Health on MSN
Obstructive vs. Nonobstructive Hypertrophic Cardiomyopathy (HCM): What Your Diagnosis Means for Treatment and Lifestyle
Learn the key differences between obstructive and nonobstructive HCM, including how your specific diagnosis can impact ...
EQT Life Sciences has exited its investment in Vivasure Medical following the sale of the Irish medical technology company to Haemonetics. Backed by EQT since 2016, Vivasure developed the PerQseal® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results